REQUEST A DEMO
Total
USD $0.00
Search more companies

Rpbio Inc. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Rpbio Inc. Profile Updated: June 19, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the manufacture and sale of health functional foods and pharmaceuticals. The Company is engaged in the production and sale of health functional foods such as multi-vitamins, collagen, lactic acid bacteria, and aloe. In addition, the Company is engaged in the production and sale of medicines such as cold medicines, painkillers, dementia prevention medicines, acne treatment medicines, and sleep improvement medicines. The Company was established on August 5, 2016. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on September 29, 2022.

Headquarters
8th Floor, 634, Samseong-ro Gangnam-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Rpbio Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Rpbio Inc. report to view the information.
Outstanding Shares:
Purchase the Rpbio Inc. report to view the information.
Registered Capital:
Purchase the Rpbio Inc. report to view the information.
Financial Auditors:
Purchase the Rpbio Inc. report to view the information.
Incorporation Date:
August 05, 2016
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Executive Director
Company Performance
Financial values in the chart are available after Rpbio Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
2.38%
Total operating revenue
2.41%
Operating profit (EBIT)
-38.47%
EBITDA
-20.53%
Net Profit (Loss) for the Period
-41.35%
Total assets
1.69%
Total equity
47.96%
Operating Profit Margin (ROS)
-3.95%
Net Profit Margin
-3.8%
Return on Equity (ROE)
-5.14%
Debt to Equity Ratio
-27.75%
Quick Ratio
0.31%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?